Koers Propanc Health Group Corp Other OTC
Aandelen
US74345C1027
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 559K 522K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -1,87 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,87 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,09 mln. 1,02 mln. | Nettoschuld 2023 | 536K 501K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,07
x | K/w-verhouding 2023 |
-0,08
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 97,69% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 50 | 15-10-07 | |
Julian Kenyon
FOU | Founder | 77 | 15-10-07 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 50 | 15-10-07 | |
Julian Kenyon
FOU | Founder | 77 | 15-10-07 |
Josef Zelinger
BRD | Director/Board Member | 74 | 23-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers PPCB
- Koers